Mestex
Basel
About Mestex
Mestex is one of the important clusters for innovative pharmaceutical industries and biotech companies in Europe. Mestex AG is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the intra-articular treatment of pain associated with osteoarthritis of the knee.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Website: mestex.ch
- Phone: [email protected]
Canonical: https://fsome.com/organization/mestex-2063540 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.